|
|
||||||||||||||
|
|
|||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHORT REPORTS |
1 Division of General Pediatrics, University of California, San Francisco, California, USA
2 Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA
3 Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington, USA
4 Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
Correspondence to:
Dr V Flaherman, University of California, San Francisco, 3333 California St, Box 0503, San Francisco, CA 94143-0503, USA; FlahermanV{at}peds.ucsf.edu
Background: A recent study proposed a risk factor scoring system for prediction of hyperbilirubinaemia that assigned increased risk to infants of higher birth weight.
Objective: To investigate this novel finding in a large, retrospective cohort analysis.
Methods: 105 384 newborns (
2000 g and
36 weeks) were analysed, and the effect of higher birth weight on total serum bilirubin (TSB)
342 µmol/l was reported using logistic regression to control for gestational age, scalp injury diagnosis, maternal diabetes, method of delivery and other confounders.
Results: The odds ratio for the effect of an additional 500 g of birth weight on TSB
342 µmol/l declined with increasing gestational age from 1.55 (95% CI 1.28 to 1.87) at 36 weeks to 1.30 (95% CI 1.12 to 1.50) at 37 weeks and 1.14 (95% CI 1.01 to 1.29) at 38 weeks. There was no association for infants
39 weeks.
Conclusion: Higher birth weight predicts TSB
342 µmol/l in 36–38 week infants, but not in infants
39 weeks. Further research should explore the causal mechanism for the association in less-mature infants.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |